This project is initiated by Xinma Biotechnology Co., Ltd. Beijing (hereafter referred to as "Xinma Biotech"), a wholly-owned subsidiary of Shineco, Inc. (Nasdaq: TYHT), a Nasdaq-listed company. The focus is on the cultivation of industrial hemp, CBD processing, and comprehensive utilization. The aim is to leverage Shinecos influence from its overseas listing to rapidly scale up operations and promote high-quality CBD processing in China, filling a market gap and becoming a leading player in Chinas industrial hemp market. Under the regulations of Regulation S and Regulation D of the U.S. SEC, 20% of preferred shares will be issued as Security Tokens, raising $20 million, which can be converted into tradable shares of the listed company as an exit route. By applying blockchain technology, all of Xinma Biotech’s industrial hemp planting data and future CBD production line operations will be recorded on the BAIC IoT public blockchain, achieving transparent management. Investors can track Xinma Biotech’s asset operations in real-time, effectively safeguarding their investments and increasing customer trust.